Please upgrade your browser

We built this website using the latest browser technologies to deliver the very best experience.

This makes the site run faster and easier to use. Unfortunately, your browser is out of date and will not support some of these technologies.

We recommend that you use a modern browser such as Google Chrome or Microsoft Edge to view this website.

Download ChromeDownload Microsoft Edge
BPm-Health Handset
Sensyne Health | Healthcare

Self-monitoring of blood pressure during pregnancy

The blood pressure management system BPm-Health allows pregnant women to self-monitor blood pressure during pregnancy enabling healthcare professionals to provide remote care for mums-to-be.
Get it on Google PlayDownload on the App Store
The need for safe remote monitoring during the COVID-19 pandemic

There has been an increasing recognition of the benefits from self-monitoring of blood pressure (‘BP’) during pregnancy - see references below.  The COVID-19 outbreak is now increasing the need for healthcare professionals to advocate BP self-monitoring to reduce face-to-face consultations for pregnant and postnatal women whilst maintaining care for the woman and her baby.


Improves care

Provides women with advice about blood pressure levels.

Gives control

Self- monitoring gives pregnant women greater control of their pregnancy care while potentially reducing the need for face-to-face clinic visits

Provides reassurance

Helps mums-to-be self-monitor blood pressure to protect themselves and their baby.

Easy, accurate monitoring

Provides an easy to use and uniform monitoring system for healthcare professionals.

Increases safety

Reduces face-to-face contact to reduce risk associated with COVID-19 infection.


All patient data is de-identified and anonymised, securely stored on the cloud as a completely isolated instance with rigorous data security and privacy measures.

BPm-Health is classified as a Medical Device and is registered as such with the UK National Competent Authority (MHRA)

Download Product Guide

Self-monitoring in pregnancy

Either to replace BP measurements on the day of a clinic or so that BP measurements may be done more frequently.

Provides advice
Self=monitoring in pregnancy

Easy to use

Provides an easy to use system for women, many of whom already informally self-monitor.

Provides advice

Provides advice on what a woman should do depending on her BP levels.

An easy to use system for women

BPm-Health is aimed at:

Women with chronic hypertension, gestational hypertension, pre-eclampsia
Women determined as high or moderate risk by NICE guidelines (see below)
All pregnant women (including those who may need to self-isolate for a period)

NICE Guidelines* identify the following groups at risk of hypertension in pregnancy:

One of  the following risk factors:
  • hypertensive disease during a previous pregnancy
  • chronic kidney disease
  • autoimmune disease (e.g. systemic lupus erythematosus orantiphospholipid syndrome)
  • type 1 or type 2 diabetes
Two or more of  the following risk factors:
  • first pregnancy
  • age 40 years or older
  • pregnancy interval of more than 10 years
  • body mass index (BMI) of 35 kg/m2 or more family history of pre-eclampsia
  • multi-fetal pregnancy

*NICE guideline [NG133] “Hypertension in pregnancy:diagnosis and management” published June 2019:


What is BPm-Health?
Who is BPm-Health intended for?
How do pregnant women access and use the app?
How does the system help maternity services?
How will BPm-Health help the NHS during and after the pandemic?
What are the main features of the app?
How much does BPm-Health cost?
Does BPm-Health store any patient sensitive data?
What is the background to the development of BPm-Health?
What clinical guidelines support the use of BPm-Health?
What is the clinical science behind BPm-Health?
Can BPm-Health be used without needing to download an app?
Does BPm-Health provide a patient diagnosis? 
Who can see the data entered into BPm-Health? 
What does anonymised data mean?
How do you protect personal and healthcare data? 


  1. Pealing LM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, et al. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. Pregnancy Hypertens. 2019; 18:141-9.

  2. Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-Management of Postnatal Hypertension: The SNAP-HT Trial. Hypertension. 2018.

  3. Tucker KL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017; 17(1):442.

  4. Hinton L, Tucker KL, Greenfield SM, Hodgkinson JA, Mackillop L, McCourt C, et al.Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women's experiences of self-monitoring. BMC Pregnancy Childbirth. 2017; 17(1):427.

  5. Hypertension in pregnancy: diagnosis and management NICE guideline [NG133] Published date: 25 June 2019

  6. ‘Self-monitoring of blood pressure in pregnancy Information for healthcare professionals Version 1’: Published Monday 30 March 2020 Royal College of Obstetricians & Gynaecologists - documents/guidelines/2020-03-30-self-monitoring-of-blood-pressure-in-pregnancy.pdf

Disclaimer: Sensyne Health are not responsible for external website content.

Note: Not all Sensyne Health products are available in all territories, for further information contact head office.